The goal is to profile RUNX2 and CBFB binding sites in an osteosarcoma cell line, SAOS2. Overall design: Fifty million of SAOS2 cells were fixed and subjected to ChIP-seq assay using RUNX2 or CBFB spe
RESEARCH ARTICLE: Identification of Genomic Alterations in Chemotherapy-Related Genes: A Preliminary Study in Three Thai Adolescents with Fatal Osteosarcoma at Maharaj Nakorn Chiang Mai Hosp
